Appointment of Agent for Service of Process and Undertaking (f-x)
June 11 2018 - 4:03PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.
20549
FORM F-X
APPOINTMENT OF AGENT FOR SERVICE OF PROCESS
AND
UNDERTAKING
A.
|
Name of issuer or person filing
|
Titan Medical Inc.
|
|
("Filer"):
|
|
B.
|
(1)
|
This is [check one]:
|
|
|
|
|
[X]
|
an original filing for the Filer
|
|
|
|
|
[ ]
|
an amended filing for the Filer
|
|
|
|
|
(2)
|
Check the following box if you are filing the
Form F-X in paper in accordance with Regulation S-T Rule 101(b)(9)
[ ]
|
C.
|
Identify the filing in conjunction with which this form
is being filed:
|
|
Name of Registrant:
|
Titan Medical Inc.
|
|
|
|
|
Form type:
|
Registration Statement on Form 40-F
|
|
|
|
|
File Number (if known):
|
001-38524
|
|
|
|
|
Filed by:
|
Titan Medical Inc.
|
Date
Filed
(if filed concurrently, so
indicate):
June 11, 2018 (filed concurrently)
D.
|
The Filer is incorporated or organized under the
provincial laws of Ontario, Canada and has its principal place of business
170 University Avenue, Suite 1000, Toronto, Ontario M5H
3B3
|
|
|
E.
|
The Filer designates and appoints
CT Corporation
System (Agent), located at 1015 15
th
Street
N.W., Suite 1000, Washington, DC 20005; telephone (202) 572-3100
as
the agent of the Filer upon whom may be served any process, pleadings,
subpoenas, or other papers in:
|
|
(a)
|
any investigation or administrative proceeding conducted
by the Commission; and
|
|
|
|
|
(b)
|
any civil suit or action brought against the Filer or to
which the Filer has been joined as defendant or respondent, in any
appropriate court in any place subject to the jurisdiction of any state or
of the United States or of any of its territories or possessions or of the
District of Columbia, where the investigation, proceeding or cause of
action arises out of or relates to or concerns: (i) any offering made or
purported to be made in connection with the securities registered or qualified
by the Filer on Form 40-F on June 11, 2018 or any purchases or sales of
any security in connection therewith; (ii) the securities in relation to which
the obligation to file an annual report on Form 40-F arises, or any purchases or
sales of such securities; (iii) any tender offer for the securities of a
Canadian issuer with respect to which filings are made by the Filer with the
Commission on Schedule 13E-4F, 14D-1F or 14D-9F; or (iv) the securities in
relation to which the Filer acts as trustee pursuant to Rule 10a-5 under the
Trust Indenture Act of 1939. The Filer stipulates and agrees that any such civil
suit or action or administrative proceeding may be commenced by the service of
process upon, and that service of an administrative subpoena shall be effected
by service upon such agent for service of process, and that service as aforesaid
shall be taken and held in all courts and administrative tribunals to be valid
and binding as if personal service thereof had been made.
|
F.
|
The Filer stipulates and agrees to appoint a successor
agent for service of process and file an amended Form F- X if the Filer
discharges the Agent or the Agent is unwilling or unable to accept service
on behalf of the Filer at any time until six years have elapsed from the
date the Filer has ceased reporting under the Exchange Act. The Filer
further undertakes to advise the Commission promptly of any change to the
Agent's name or address during the applicable period by amendment of this
Form, referencing the file number of the relevant form in conjunction with
which the amendment is being filed.
|
|
|
G.
|
The Filer undertakes to make available, in person or by
telephone, representatives to respond to inquiries made by the Commission
staff, and to furnish promptly, when requested to do so by the Commission
staff, information relating to the forms, schedules, and offering
statements described in General Instructions I.(a), I. (b), I.(c), I.(d)
and I.(f) of this Form, as applicable; the securities to which such forms,
schedules and offering statements relate, and the transaction in such
securities.
|
The Filer certifies that it has duly caused this power of
attorney, consent, stipulation and agreement to be signed on its behalf by the
undersigned, thereto duly authorized, in Toronto, Ontario this 11
th
day of
June 2018.
TITAN MEDICAL INC.
By:
/s/ Stephen Randall
Name: Stephen Randall
Title:
Chief Financial Officer
This statement has been signed by the following person in the
capacity and on the date indicated:
CT CORPORATION SYSTEM
(Agent for Service)
By:
/s/ Candice
Pignataro
Name: Candice Pignataro
Title: Assistant
Secretary
Dated: June 11, 2018
Titan Medical (NASDAQ:TMDI)
Historical Stock Chart
From Aug 2024 to Sep 2024
Titan Medical (NASDAQ:TMDI)
Historical Stock Chart
From Sep 2023 to Sep 2024